N,N-Dimethyl-DL-methionin | 2812-23-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N,N-Dimethyl-DL-methionin
• 英文别名: N,N-dimethyl-DL-methionine；Dimethylmethionine；2-(dimethylamino)-4-methylsulfanylbutanoic acid
• CAS: 2812-23-9
• 化学式: C₇H₁₅NO₂S
• 分子量: 177.268
• InChiKey: FLEXUHXAXRFRAU-UHFFFAOYSA-N

物化性质

• 沸点：
  292.1±35.0 °C(Predicted)
• 密度：
  1.105±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  65.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (S)-2-bromo-4-methylsulfanyl-butyric acid 在 溶剂黄146 作用下， 生成 N,N-Dimethyl-DL-methionin
  参考文献：
  名称：

  Sakieki; Mituno, Nippon Kagaku Zasshi, 1959, vol. 80, p. 1035,1036

  摘要：

  DOI：

文献信息

• [EN] NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY<br/>[FR] COMPOSITIONS DE NANOMATÉRIAU, SYNTHÈSE ET ASSEMBLAGE
  申请人：RHODE ISLAND HOSPITAL

  公开号：WO2016081522A1

  公开（公告）日：2016-05-26

  Compositions or an assembly of a series of biomimetic compounds include chemical structures that mimic or structurally resemble a nucleic acid base pair. Complexes of nanotubes and agents are useful to deliver agents into the cells or bodily tissues of individuals for therapeutic and diagnostic purposes. Exemplary compounds include those of Formula (I), (III), (V) or (VII), or of Formula (II), (IV), (VI) or (VIII).

  一系列仿生化合物的组成或装配包括模拟或在结构上类似于核酸碱基对的化学结构。纳米管和试剂的复合物可用于将试剂输送到个体的细胞或身体组织中，用于治疗和诊断目的。示例化合物包括Formula (I)、(III)、(V)或(VII)的化合物，或Formula (II)、(IV)、(VI)或(VIII)的化合物。
• PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS
  申请人：Aicher Thomas Daniel

  公开号：US20130184257A1

  公开（公告）日：2013-07-18

  Compounds of Formula (I) and pharmaceutically acceptable salts thereof in which X 1 , X 2 , L, R 3 , R 4 , R 5 , R 7 and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.

  公式（I）的化合物及其药学上可接受的盐，其中X1、X2、L、R3、R4、R5、R7和n的含义如规范中所给出，是GPR119的调节剂，并可用于治疗或预防疾病，例如但不限于2型糖尿病、糖尿病并发症、糖尿病症状、代谢综合征、肥胖症、血脂异常和相关疾病。
• RESIST PROTECTIVE COATING COMPOSITION AND PATTERNING PROCESS
  申请人：HARADA Yuji

  公开号：US20090286182A1

  公开（公告）日：2009-11-19

  A protective coating composition comprising a copolymer of an alkali-soluble (α-trifluoromethyl)acrylate and a norbornene derivative as a base polymer, optionally in admixture with a second polymer containing sulfonic acid and/or sulfonic acid amine salt in repeat units is applied onto a resist film. The protective coating is effective in minimizing development defects and forming a resist pattern of improved profile.
• US20140256756A1
  申请人：——

  公开号：US20140256756A1

  公开（公告）日：2014-09-11
• NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY
  申请人：Rhode Island Hospital

  公开号：US20170362238A1

  公开（公告）日：2017-12-21

  Compositions or an assembly of a series of biomimetic compounds include chemical structures that mimic or structurally resemble a nucleic acid base pair. Complexes of nanotubes and agents are useful to deliver agents into the cells or bodily tissues of individuals for therapeutic and diagnostic purposes. Exemplary compounds include those of Formula (I), (III), (V) or (VII), or of Formula (II), (IV), (VI) or (VIII).